RHOA and cardiomyopathy: In addition to the lower left ventricular ejection fraction (LVEF), LV dilatation and increased LV mass without LV wall thickening during the experimental period were observed in the RhoA cKO hearts compared with the control hearts (Fig. 1, F–H), suggesting age-dependent cardiomyopathy caused by loss of RhoA in the heart.